RecruitingNCT07249996

Respiratory Infections in Young Children

Respiratory Infections in Young Children in Colombia and Panamá: Epidemiology, Interactions, and Long-term Consequences.


Sponsor

Eduardo Lopez -Medina

Enrollment

1,088 participants

Start Date

May 2, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn about the causes, severity, and long-term effects of respiratory tract infections (RTIs) in young children from birth to five years of age in Colombia and Panamá. The main questions it aims to answer are: How often do respiratory infections occur in children under two years old, and which viruses or bacteria cause them? Why do some children develop more severe infections than others? Do early infections or vaccinations change how the immune system responds to future illnesses? How do viruses and bacteria interact in the respiratory tract to influence disease severity and long-term respiratory health? Researchers will follow newborns from birth until age five to understand how respiratory infections develop and affect children's health over time. Participants will not receive any experimental treatment. Families who join the study will: Be contacted twice a week through a phone app or phone calls to check for symptoms of respiratory infection. Attend in-person visits if their child becomes ill and every six months for routine follow-up. Provide nasal and blood samples during illness episodes so researchers can identify the viruses or bacteria causing infection and study how the immune system responds. This study began in May 2024 and is being conducted in Cali, Colombia, and Panamá City, Panamá. The research team plans to continue to include participants and continue active follow-up until the children reach five years of age. The information collected will help scientists and health professionals understand how different pathogens cause respiratory infections, what factors increase the risk of severe illness, and how early infections may influence long-term lung health. The study's findings will support future efforts to prevent and treat respiratory diseases in young children.


Eligibility

Max Age: 29 Days

Inclusion Criteria4

  • Newborns younger than 29 days of life, with or without pre-existing conditions
  • Infants whose parent(s) or guardian(s) are available for telephone contact for the duration of the study, and do not intend to relocate outside of the study area, to ensure adherence to RTI and in-person visits.
  • Infants whose parent(s) or guardian(s) provide informed consent to participate in the study.
  • Infants whose parent(s) or guardian(s) are willing to authorize data and specimen collection, storage and analysis.

Exclusion Criteria1

  • Infants born to a pregnant mother under 14 years of age (under Colombian law, pregnancies occurring in individuals younger than 14 years of age are legally presumed to result from sexual abuse).

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Centro de Estudios en Infectologia Pediatrica, CEIP

Cali, Valle del Cauca Department, Colombia

Cevaxin

Panama City, Panama

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07249996


Related Trials